title: Injectable success: from fillers to Botox.
abstract: The educated consumer seeks minimal downtime options to address the early signs of aging. These signs include a deepening of facial folds, an increase in muscle-induced wrinkling, and even a loss of facial volume. The use of fillers both dermal and subdermal and the use of the neurotoxin Botox have grown tremendously. The increase demand for these nonsurgical options for facial rejuvenation has created an added responsibility for physicians to remain current in injection technique and product safety. My technique has evolved, along with the predictability of the current fillers and our understanding of the actions of these products, from a safe and conservative fellowship base. A successful injector is one who understands the limitations and possibilities of the available fillers as well as the neurotoxin Botox. The happy patient is one who finds that doctor.
authors.affiliation: Peconic Facial Plastic Surgery, Aquebogue, NY 11931, USA.
authors.forename: Paul E
authors.initials: PE
authors.lastname: Kelly
mesh_terms: D001672:Biocompatible Materials / Q000008:administration & dosage / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D002482:Cellulose / Q000008:administration & dosage / Q000627:therapeutic use; D003094:Collagen / Q000008:administration & dosage / Q000627:therapeutic use; D003357:Cosmetic Techniques; D017886:Durapatite / Q000008:administration & dosage / Q000627:therapeutic use; D004867:Equipment Design; D005143:Eyelids / Q000473:pathology; D005145:Face; D005546:Forehead / Q000473:pathology; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D007279:Injections, Subcutaneous / Q000295:instrumentation / Q000379:methods; D019344:Lactic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D008046:Lip / Q000473:pathology; D008353:Mannitol / Q000008:administration & dosage / Q000627:therapeutic use; D009339:Needles; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018579:Patient Selection; D011108:Polymers / Q000008:administration & dosage / Q000627:therapeutic use; D012060:Rejuvenation; D015595:Skin Aging / Q000473:pathology
chemical_list: D001672:Biocompatible Materials; D009465:Neuromuscular Agents; C482305:New-Fill; D011108:Polymers; D019344:Lactic Acid; D008353:Mannitol; D002482:Cellulose; D006820:Hyaluronic Acid; D003094:Collagen; D017886:Durapatite; D019274:Botulinum Toxins, Type A